Literature DB >> 21779507

The Role of p53 in Metabolic Regulation.

Anna M Puzio-Kuter1.   

Abstract

The metabolic changes that occur in a cancer cell have been studied for a few decades, but our appreciation of the complexity and importance of those changes is now being realized. The metabolic switch from oxidative phosphorylation to aerobic glycolysis provides intermediates for cell growth and division and is regulated by both oncogenes and tumor suppressor genes. The p53 tumor suppressor gene has long been shown to play key roles in responding to DNA damage, hypoxia, and oncogenic activation. However, now p53 has added the ability to mediate metabolic changes in cells through the regulation of energy metabolism and oxidative stress to its repertoire of activities. It is therefore the focus of this review to discuss the metabolic pathways regulated by p53 and their cooperation in controlling cancer cell metabolism.

Entities:  

Keywords:  aerobic glycolysis; oxidative phosphorylation; oxidative stress; p53

Year:  2011        PMID: 21779507      PMCID: PMC3135642          DOI: 10.1177/1947601911409738

Source DB:  PubMed          Journal:  Genes Cancer        ISSN: 1947-6019


  59 in total

1.  p53 has a direct apoptogenic role at the mitochondria.

Authors:  Motohiro Mihara; Susan Erster; Alexander Zaika; Oleksi Petrenko; Thomas Chittenden; Petr Pancoska; Ute M Moll
Journal:  Mol Cell       Date:  2003-03       Impact factor: 17.970

2.  THE FEEDBACK CONTROL OF SUGAR NUCLEOTIDE BIOSYNTHESIS IN LIVER.

Authors:  S KORNFELD; R KORNFELD; E F NEUFELD; P J O'BRIEN
Journal:  Proc Natl Acad Sci U S A       Date:  1964-08       Impact factor: 11.205

3.  On respiratory impairment in cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-08-10       Impact factor: 47.728

4.  Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro.

Authors:  G MEDES; A THOMAS; S WEINHOUSE
Journal:  Cancer Res       Date:  1953-01       Impact factor: 12.701

5.  TIGAR, a p53-inducible regulator of glycolysis and apoptosis.

Authors:  Karim Bensaad; Atsushi Tsuruta; Mary A Selak; M Nieves Calvo Vidal; Katsunori Nakano; Ramon Bartrons; Eyal Gottlieb; Karen H Vousden
Journal:  Cell       Date:  2006-07-14       Impact factor: 41.582

6.  Regulation of PTEN transcription by p53.

Authors:  V Stambolic; D MacPherson; D Sas; Y Lin; B Snow; Y Jang; S Benchimol; T W Mak
Journal:  Mol Cell       Date:  2001-08       Impact factor: 17.970

7.  REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species.

Authors:  Leif W Ellisen; Kate D Ramsayer; Cory M Johannessen; Annie Yang; Hideyuki Beppu; Karolina Minda; Jonathan D Oliner; Frank McKeon; Daniel A Haber
Journal:  Mol Cell       Date:  2002-11       Impact factor: 17.970

8.  S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that contains GAPDH as a key component.

Authors:  Lei Zheng; Robert G Roeder; Yan Luo
Journal:  Cell       Date:  2003-07-25       Impact factor: 41.582

9.  p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis.

Authors:  S Perwez Hussain; Paul Amstad; Peijun He; Ana Robles; Shawn Lupold; Ichiro Kaneko; Masato Ichimiya; Sagar Sengupta; Leah Mechanic; Shu Okamura; Lorne J Hofseth; Matthew Moake; Makoto Nagashima; Kathleen S Forrester; Curtis C Harris
Journal:  Cancer Res       Date:  2004-04-01       Impact factor: 12.701

10.  Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses.

Authors:  Kyong-Ah Yoon; Yusuke Nakamura; Hirofumi Arakawa
Journal:  J Hum Genet       Date:  2004-02-25       Impact factor: 3.172

View more
  111 in total

1.  Targeting tumor suppressor networks for cancer therapeutics.

Authors:  Xuning Emily Guo; Bryan Ngo; Aram Sandaldjian Modrek; Wen-Hwa Lee
Journal:  Curr Drug Targets       Date:  2014-01       Impact factor: 3.465

2.  Combining p53 stabilizers with metformin induces synergistic apoptosis through regulation of energy metabolism in castration-resistant prostate cancer.

Authors:  Long Chen; Nihal Ahmad; Xiaoqi Liu
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

3.  Introduction: The Changing Directions of p53 Research.

Authors:  Arnold J Levine
Journal:  Genes Cancer       Date:  2011-04

Review 4.  Determinants of nutrient limitation in cancer.

Authors:  Mark R Sullivan; Matthew G Vander Heiden
Journal:  Crit Rev Biochem Mol Biol       Date:  2019-06-04       Impact factor: 8.250

Review 5.  Probing carbohydrate metabolism using hyperpolarized 13 C-labeled molecules.

Authors:  Jaspal Singh; Eul Hyun Suh; Gaurav Sharma; Chalermchai Khemtong; A Dean Sherry; Zoltan Kovacs
Journal:  NMR Biomed       Date:  2018-11-26       Impact factor: 4.044

Review 6.  The ketogenic diet for the treatment of malignant glioma.

Authors:  Eric C Woolf; Adrienne C Scheck
Journal:  J Lipid Res       Date:  2014-02-06       Impact factor: 5.922

7.  Metabolism and glioma therapy.

Authors:  Eric C Woolf; Adrienne C Scheck
Journal:  CNS Oncol       Date:  2012-09

8.  p53 and ATF4 mediate distinct and additive pathways to skeletal muscle atrophy during limb immobilization.

Authors:  Daniel K Fox; Scott M Ebert; Kale S Bongers; Michael C Dyle; Steven A Bullard; Jason M Dierdorff; Steven D Kunkel; Christopher M Adams
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-06-03       Impact factor: 4.310

9.  Inhibition of glutathione synthesis distinctly alters mitochondrial and cytosolic redox poise.

Authors:  Vladimir L Kolossov; William P Hanafin; Jessica N Beaudoin; Denisa E Bica; Stephen J DiLiberto; Paul J A Kenis; H Rex Gaskins
Journal:  Exp Biol Med (Maywood)       Date:  2014-02-28

Review 10.  Chemical metabolic inhibitors for the treatment of blood-borne cancers.

Authors:  Martin Villalba; Nuria Lopez-Royuela; Ewelina Krzywinska; Moeez G Rathore; Robert A Hipskind; Houda Haouas; Nerea Allende-Vega
Journal:  Anticancer Agents Med Chem       Date:  2014-02       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.